Growth Metrics

Integra Lifesciences Holdings (IART) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -2.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.71%
Dec 31, 2025 13.97%
Sep 30, 2025 -45.07%
Jun 30, 2025 -68.84%
Mar 31, 2025 -36.68%
Dec 31, 2024 46.33%
Sep 30, 2024 -7.05%
Jun 30, 2024 -243.97%
Mar 31, 2024 22.86%
Dec 31, 2023 -16.79%
Sep 30, 2023 -4.64%
Jun 30, 2023 -57.90%
Mar 31, 2023 13.92%
Dec 31, 2022 -38.56%
Sep 30, 2022 28.79%
Jun 30, 2022 36.31%
Mar 31, 2022 3.81%
Dec 31, 2021 -2.76%
Sep 30, 2021 19.66%
Jun 30, 2021 -102.09%
Mar 31, 2021 -132.97%
Dec 31, 2020 66.82%
Sep 30, 2020 1.86%
Jun 30, 2020 52.78%
Mar 31, 2020 51.91%
Dec 31, 2019 0.85%
Sep 30, 2019 -153.17%
Jun 30, 2019 -29.37%
Mar 31, 2019 -32.92%
Dec 31, 2018 12.51%
Sep 30, 2018 62.72%
Jun 30, 2018 28.70%
Mar 31, 2018 -65.24%
Dec 31, 2017 -115.08%
Sep 30, 2017 6.79%
Jun 30, 2017 -58.87%
Mar 31, 2017 7.79%
Dec 31, 2016 -66.54%
Sep 30, 2016 20.59%
Jun 30, 2016 16.24%
Mar 31, 2016 19.88%
Dec 31, 2015 -8.30%
Sep 30, 2015 -161.53%
Jun 30, 2015 -20.33%
Mar 31, 2015 68.16%
Dec 31, 2014 -85.15%
Sep 30, 2014 52.30%
Jun 30, 2014 52.63%
Mar 31, 2014 -246.49%
Dec 31, 2013 38.05%
Sep 30, 2013 -14.36%
Dec 31, 2012 23.80%
Sep 30, 2012 62.53%